BioCryst Pharmaceuticals, Inc. (BCRX)

9.34 -0.22 (-2.30%) USD  |  NASDAQ  |  Mar 27, 16:00
9.39 +0.05 (+0.54%) After-Hours: 20:00
More

BioCryst Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Anika Therapeutics, Inc. Upgrade
Lantheus Holdings, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
BioStem Technologies, Inc. Upgrade